-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
| WHO releases new guidelines for cervical cancer screening, first HPV-DNA testing |
Xinhua News Agency, Geneva, July 6.
Cervical cancer is a preventable and curable disease, but a large number of women still die of cervical cancer every year around the world
.
The World Health Organization and the United Nations Special Programme for Human Reproduction jointly issued a new guide on the 6th to help countries better carry out cervical cancer screening and treatment, which recommends HPV-DNA (human papillomavirus-deoxyribonucleic acid) testing As the preferred screening method for cervical cancer screening
WHO data shows that there will be more than 500,000 new cases of cervical cancer worldwide in 2020, and about 340,000 women will die of cervical cancer
.
Human papillomavirus is considered to be the main culprit for cervical cancer and other cancers.
Compared with the previous guidelines, the new guidelines make some important changes in cervical cancer screening
.
At present, the commonly used screening method for cervical precancerous lesions is mainly "smear examination", and the new guidelines recommend HPV-DNA testing as the preferred screening method
The new guidelines say that HPV-DNA testing can detect high-risk strains of human papillomavirus
.
Unlike the smear method that relies on visual observation, HPV-DNA testing is an objective diagnosis
The World Health Organization calls for women around the world to regularly undergo cervical cancer screenings in accordance with the recommendations of local medical institutions
.
However, some women with impaired immune function, such as those infected with HIV , are more likely to suffer from cervical disease and will develop into precancerous lesions and cervical cancer more quickly
AIDS AIDS
The new guidelines emphasize that ordinary women can be screened for cervical cancer from the age of 30, while women living with HIV must be screened before the age of 25
AIDS
